State Biotech Advocates Share Best Practices

Last week the Council of State Bioscience Associations (CSBA) held its annual retreat in Austin, TX, where 42 different state-based bioscience advocacy organization gathered to discuss legislative and regulatory best practices that support bioscience industry development.

More than 90 invited participants engaged in discussions covering the topics of economic development initiatives, upcoming federal and state legislative industry priorities, and advocacy campaigns in the digital era.

BIO’s State Government Relations team would like to once again extend our gratitude to Tom Kowalski of the Texas Healthcare & Bioscience Institute. Tom has been a longtime participant in the CSBA, previously serving as the board chair, and he is a current board member. In addition to being an invaluable resource to other members within the council, he was a gracious host at this year’s retreat. Thank you, Tom!

In addition to Pete Pellerito’s role as the Interim Vice President of State Government Relations and Alliance Development at BIO, he is presently the executive director of the CSBA. Pete has been a mainstay and principal advisor through the 15 year history of the association. Pete has also been an important element of the CSBA’s growth through his participation in the creation of numerous state bioscience associations.

We are pleased to have these distinguished state trade association leaders from across the nation come together to collaborate and share insights on vital economic development and regulatory matters facing our industry. These groups are recognized by BIO as affiliate organizations in their respective states. We look forward to the council’s continued engagement as we keep our industry vibrant and competitive in an increasingly global economy.

Events  |  Email This Post  |  Printer Friendly
Tags: , , ,

One Response to State Biotech Advocates Share Best Practices

  1. BSPM is currently followed by 2 analysts. Both give the stock a positive rating. The average price target is 8.07, which implies 1,222.13% upside from current price.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>